SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-007784
Filing Date
2020-03-10
Accepted
2020-03-10 18:18:54
Documents
2
Period of Report
2020-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2866
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3510
  Complete submission text file 0000899243-20-007784.txt   7777
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MAGENTA THERAPEUTICS, INC. 100 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Stants Kristen (Reporting) CIK: 0001805727 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38541 | Film No.: 20703312